Enlarge this image Sarepta Therapeutics was awarded a voucher for a fast-track drug review by the Food and Drug Administration when the…
Enlarge this image Sarepta Therapeutics was awarded a voucher for a fast-track drug review by the Food and Drug Administration when the…
Enlarge this image Duchenne muscular dystrophy patients Jack Willis (center), Nolan Willis (right) and Max LeClaire, attended the opening of Sarepta Therapeutics…